⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference
businesswire.com
TEM
Form 8-K
sec.gov
TEM
Tempus Reports Fourth Quarter and Full Year 2025 Results
businesswire.com
TEM
eyonis® LCS démarre sa commercialisation aux États‑Unis après l’obtention de l’autorisation FDA ; Oran Muduroglu est nommé Président de Median eyonis Inc.
businesswire.com
TEM
eyonis® LCS démarre sa commercialisation aux États‑Unis après l’obtention de l’autorisation FDA ; Oran Muduroglu est nommé Président de Median eyonis Inc.
businesswire.com
TEM
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
businesswire.com
TEM
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
businesswire.com
TEM
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
businesswire.com
TEM
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
businesswire.com
TEM
Median Technologies annonce sa collaboration avec Tempus pour développer l’accès au logiciel dispositif médical eyonis ® LCS aux États‑Unis
businesswire.com
TEM